FIBROGELNET
Network for Development of Soft Nanofibrous Construct for Cellular Therapy of Degenerative Skeletal Disorders
| Coordinatore | FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Organization address
address: CARRER BALDIRI REIXAC PLANTA 2A 10-12 contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 910˙726 € |
| EC contributo | 910˙726 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2012-IAPP |
| Funding Scheme | MC-IAPP |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-01-01 - 2017-06-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
Organization address
address: CARRER BALDIRI REIXAC PLANTA 2A 10-12 contact info |
ES (BARCELONA) | coordinator | 486˙301.33 |
| 2 |
BIO ELPIDA SAS
Organization address
address: CHEMIN DES PEUPLIERS 27 contact info |
FR (DARDILLY) | participant | 178˙608.17 |
| 3 |
TYKANNA BANKA-BULGEN
Organization address
address: UL. HRISTO BLAGOEV 25-31 contact info |
BG (SOFIA) | participant | 93˙356.68 |
| 4 |
GENEKAM BIOTECHNOLOGY AG
Organization address
address: DAMMSTRASSE 31 contact info |
DE (DUISBURG) | participant | 68˙446.62 |
| 5 |
UNIVERSITAT POLITECNICA DE VALENCIA
Organization address
address: CAMINO DE VERA SN EDIFICIO 3A contact info |
ES (VALENCIA) | participant | 33˙579.95 |
| 6 |
MARTIN-LUTHER-UNIVERSITAET HALLE-WITTENBERG
Organization address
address: UNIVERSITAETSPLATZ 10 contact info |
DE (HALLE (Saale)) | participant | 28˙674.36 |
| 7 |
UNIVERSITY OF GLASGOW
Organization address
address: University Avenue contact info |
UK (GLASGOW) | participant | 21˙759.32 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'High incidence of degenerative skeletal tissue disorders in a progressively aging human population make tissue engineering of cartilage and bone a focus of extensive research. Bone and joint disorders are the most common disease in Europe: more than 100 million European citizens suffer from arthritis and 19 million people have osteoporosis (one of three women and one of eight men are affected). This proposal is designed to supplement the existing EuroNanoMed project aimed to develop an innovative strategy for targeting bone and cartilage regeneration. More specifically the proposal seeks to set up an international multidisciplinary team of young scientists and engineers representing both academia and industry partners that will strongly contribute to the design of a novel type of implant, which can strongly promote tissue regeneration combining high performance materials, advanced nanotechnology and living cells.'